David Onions, V.W. Brinkerhoff, Joshua Boger, Joseph Scodari, Andrew Baum, Mark Skaletsky, Salvatore Salamone, James Pusey | GenomeWeb
BioReliance has appointed David Onions its chief scientific officer, effective June 18. Onions will run the company’s global clinical and preclinical scientific activities, the company said. Onions comes to BioReliance from Invitrogen, where he was chief medical officer.
 

 
Gene Logic has promoted V.W. Brinkerhoff to the post of senior vice president of administration. He will receive a $100,000 cash incentive bonus and a $250,000 executive cash incentive target for 2007.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.